FR2354M - Composition a base de stéroide et d'acide 2-méthyl-3-indolyl-aliphatique pour le traitement des inflammations. - Google Patents

Composition a base de stéroide et d'acide 2-méthyl-3-indolyl-aliphatique pour le traitement des inflammations.

Info

Publication number
FR2354M
FR2354M FR906853A FR906853A FR2354M FR 2354 M FR2354 M FR 2354M FR 906853 A FR906853 A FR 906853A FR 906853 A FR906853 A FR 906853A FR 2354 M FR2354 M FR 2354M
Authority
FR
France
Prior art keywords
steroids
indolyl
inflammation
methyl
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR906853A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Application granted granted Critical
Publication of FR2354M publication Critical patent/FR2354M/fr
Active legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D209/22—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with an aralkyl radical attached to the ring nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D209/26—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with an acyl radical attached to the ring nitrogen atom
    • C07D209/28—1-(4-Chlorobenzoyl)-2-methyl-indolyl-3-acetic acid, substituted in position 5 by an oxygen or nitrogen atom; Esters thereof

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
FR906853A 1961-08-14 1962-08-13 Composition a base de stéroide et d'acide 2-méthyl-3-indolyl-aliphatique pour le traitement des inflammations. Active FR2354M (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US13109361A 1961-08-14 1961-08-14

Publications (1)

Publication Number Publication Date
FR2354M true FR2354M (fr) 1964-02-24

Family

ID=22447849

Family Applications (1)

Application Number Title Priority Date Filing Date
FR906853A Active FR2354M (fr) 1961-08-14 1962-08-13 Composition a base de stéroide et d'acide 2-méthyl-3-indolyl-aliphatique pour le traitement des inflammations.

Country Status (3)

Country Link
CY (1) CY319A (fr)
FR (1) FR2354M (fr)
GB (1) GB970440A (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996003132A1 (fr) * 1994-07-28 1996-02-08 Psorial, L.L.C. Compositions pharmaceutiques a effet synergique a base d'acetonide de triamcinolone et de halcinonide

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT95692A (pt) * 1989-10-27 1991-09-13 American Home Prod Processo para a preparacao de derivados de acidos indole-,indeno-,piranoindole- e tetra-hidrocarbazole-alcanoicos, ou quais sao uteis como inibidores de pla2 e da lipoxigenase
US5510368A (en) * 1995-05-22 1996-04-23 Merck Frosst Canada, Inc. N-benzyl-3-indoleacetic acids as antiinflammatory drugs
EP1594471B1 (fr) * 2003-02-20 2009-03-25 Constant Research & Development Limited Procédé de fabrication d'une formulation contenant de la dexaméthasone pour administration orale

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996003132A1 (fr) * 1994-07-28 1996-02-08 Psorial, L.L.C. Compositions pharmaceutiques a effet synergique a base d'acetonide de triamcinolone et de halcinonide
US5707981A (en) * 1994-07-28 1998-01-13 Psorial, L.L.C. Synergistic pharmaceutical compositions
USRE36606E (en) * 1994-07-28 2000-03-07 Massa Technology S.A. Synergistic pharmaceutical compositions

Also Published As

Publication number Publication date
GB970440A (en) 1964-09-23
CY319A (en) 1965-10-01

Similar Documents

Publication Publication Date Title
CH425755A (fr) Procédé de préparation d'agents anti-inflammatoires
FR1593M (fr) Compositions pour le traitement de l'acne.
FR2354M (fr) Composition a base de stéroide et d'acide 2-méthyl-3-indolyl-aliphatique pour le traitement des inflammations.
FR1009M (fr) Médicament pour le traitement de l'angine de poitrine.
FR1438M (fr) Nouveau médicament efficace dans le traitement de l'athérosclérose.
FR1403611A (fr) Cage d'écrou
BE605476A (fr) Composition vétérinaire pour le traitement de l'entérohépatite chez le dindon
FR3397M (fr) Amides de l'acide isoindolinyl-2-acétique.
BE612470A (fr) Procédé de raffinage de l'amyloglucosidase
FR284M (fr) Médicament a base de 17-acétate de la 6 alpha-méthyl-9 alpha-fluoro-11 béta, 17 alpha-dihydroxy-1,4-prégnadiene-3,20-dione pour le traitement de l'aménorrhée.
FR1857M (fr) Nouveau médicament notamment pour le traitement des maladies d'origine virale.
FR1039M (fr) Médicament a base de ribonucléase pour le traitement du psoriasis et autres dermatoses.
FR1299760A (fr) Procédé de raffinage de l'amyloglucosidase
BE625105A (fr) Procédé pour la préparation de l'acide acétique pur et concentré.
FR1808M (fr) Association d'acide acéthylsalicylique et de deltahydrocortisone.
FR2863M (fr) Nouveaux esters d'oestradiol.
FR1904M (fr) Médicament a base d'acide n-acyl-hydroxyamino-acétique pour le traitement des tumeurs.
FR1596M (fr) Médicament pour le traitement de l'alcoolisme.
FR1284M (fr) Médicament pour le traitement de l'aménorrhée primaire hypogonadotrophique et d'affections dérivées.
FR1143M (fr) Médicament a base de dérivé pyimidique, notamment pour le traitement de l'hypercholestérolémie et de l'hyper-uricémie.
FR2908M (fr) Compositions pour le traitement de l'hypercholestérolémie.
FR1466M (fr) Nouveau médicament notamment pour le traitement de l'hypertension artérielle.
FR1512M (fr) Nouveau médicament notamment pour le traitement de l'hypertension artérielle.
FR1122M (fr) Nouveau médicament notamment pour le traitement de l'hypercholestérolémie.
FR1286330A (fr) Perfectionnements apportés au traitement de l'acier doux